Drawing for MACUNEOS

USPTO serial 79206825

MACUNEOS

Reviewed by CopyMark Law Group

Reg. 5415119Status 709
Filing date
Status date
Registration date
Mar 6, 2018
Examiner
ANDERSON, CASSONDRA CR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MACUNEOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia A. Moyer

Cynthia A. Moyer Fredrikson & Byron, P.A.200 South Sixth StreetSuite 4000Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
003Soaps, namely perfumed soaps, beauty soaps, shaving soaps, bath soaps, cosmetic soaps; perfumes, essential oils, cosmetics, hair lotions; cosmetic preparations for slimming purposes for external useSECTION 71 - CANCELLED—
005Pharmaceutical products for the prevention and treatment of aging diseases, namely, Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, sarcopenia, cardiovascular diseases, diabetes, spinal cord disorders, age-related macular degeneration (ARMD), diabetic retinopathy and other retinopathy as pigmentary retinitis or Stargaardt diseases, ocular diseases; dietetic substances and foods for medical use; food supplements for human beings; sanitary products for medical purposes, namely, medicinal astringents, disinfectants for medical instruments, body care soaps, disinfectant soaps, personal soaps, antifungal creams for medical use, lotions for the body and shampoos without rinsing, rubbing alcohol for medical use, skin cleansers for medical use; medical plasters; materials for medical dressings, namely, bandages, dressings and medical gauzes, absorbent cotton for bandages, bands and strips for bandages; material for stopping teeth and for dental impressions; disinfectants; vermin destroying preparations; fungicides; herbicides; medicated baths preparations; sanitary pads, panties or towels; chemical preparations for medical use, namely, chemical preparations for reactive preparations for clinical laboratory, diagnostic preparations for medical laboratory; chemical preparations for pharmaceutical use, namely, preventive pharmaceutical agents for cerebral hemorrhage, release agents of medicines in the form of edible wafers for the conditioning of pharmaceutical products in the form of powder, pharmaceutical astringents, esters of celluloses for the manufacturing of pharmaceutical products; parasiticides; dietetic sugar for medical use; alloys of precious metals for dental use; dietetic substances for medical use produced by organic farming or made with goods produced by organic farming, food for babiesSECTION 71 - CANCELLED—
042Evaluations, assessments and research in the field of science and technology provided by engineers; research and development of new products for others; technical project studies in scientific and technologic fields, namely, feasibility study; technological studies in the field of pharmaceutical research and development; technical research in the field of pharmaceutical research and development; research in the field of pharmaceutical products; biological, clinical and medical research services; biotechnological research; scientific research for medical purposes in the field of pharmaceutical products to treat dry age-related macular degeneration and diseases of ageing; computer-aided scientific research services in the field of pharmaceutical products to treat dry age-related macular degeneration and diseases of ageing; providing information relating to scientific research; preparation of reports relating to scientific research; advice relating to research and development in the therapeutic field; providing information and data relating to medical and veterinary research and development; design and development of computers and software; installation, maintenance and updating or rental of software; programming for computers; consultancy relating to computers; conversion of computer programs and data other than physical conversion; conversion of documents from a physical medium to an electronic mediumSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 18, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 25, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 24, 2025INPCINVALIDATION PROCESSED—
May 20, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 20, 2024C71TCANCELLED SECTION 71—
Mar 6, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 13, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 8, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 8, 2018FIMPFINAL DISPOSITION PROCESSED—
Jun 6, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 6, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 19, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 19, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 15, 2017GPNXNOTIFICATION PROCESSED BY IB—
Nov 29, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 29, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 29, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Nov 14, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 14, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 14, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 8, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 24, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 9, 2017ALIEASSIGNED TO LIE—
Sep 22, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2017RFNTREFUSAL PROCESSED BY IB—
May 16, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 16, 2017RFRRREFUSAL PROCESSED BY MPU—
May 13, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 10, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 9, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2017DOCKASSIGNED TO EXAMINER—
May 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance